Cancer BiologybioRxivPreprint
Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic Cancer
Alica K. Beutel, Sabrina E. Calderon, Ethan Nghiem…·Christopher J. Halbrook
This study identifies mevalonate biosynthesis as a therapeutic target and biomarker for gemcitabine-resistant pancreatic cancer.